Alex Martin

Alex Martin currently serves as the Chief Executive Officer at Abcuro, Inc. since October 2022 and has held multiple leadership roles across several biopharmaceutical companies. In addition to the CEO position, Alex is Chairman of the Board at VERALOX Therapeutics and serves as a Director at ESSA Pharmaceuticals. Previous roles include CEO of Palladio Biosciences, CEO of Realm Therapeutics, and Board Director at RASNA THERAPEUTICS LIMITED. Alex's extensive experience in the industry is complemented by an MBA from Harvard Business School and a BA in Political Science and Government from Cornell University.